Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of November 26, 2024 • 6:01 PM ET
Date/Time | Source | News Release |
---|---|---|
11/25/2024 04:05 PM EST | GlobeNewswire | Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer's Disease and Provides Business Update |
11/28/2023 07:00 AM EST | GlobeNewswire | Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs |
02/07/2019 03:18 PM EST | GlobeNewswire | Nasdaq Welcomes Alector, Inc. (Nasdaq: ALEC) to the Nasdaq Stock Market |
As of November 26, 2024 • 6:01 PM ET
Date/Time | Source | News Release |
---|---|---|
11/26/2024 05:04 AM EST | SeekingAlpha | Biggest stock movers Tuesday: PSTX, SMTC, ALEC, LESL, WWD and more |
11/25/2024 04:45 PM EST | SeekingAlpha | Alector drops 31% as Alzheimer's candidate fails in phase 2 trial |
11/19/2024 05:00 PM EST | KlickAnalytics | ALEC Price Target Alert: $4.00. Issued by Goldman Sachs |
12/05/2023 09:55 AM EST | Zacks | Wall Street Analysts Think Alector (ALEC) Could Surge 142.53%: Read This Before Placing a Bet |
11/14/2023 09:35 AM EST | Zacks | Alector (ALEC) Loses -38.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner |
02/09/2019 11:13 AM EST | SeekingAlpha | U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs |
02/07/2019 02:40 AM EST | SeekingAlpha | Alector prices IPO at $19 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.